MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

104 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-13

Study Completion Date

2023-10-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study concerns elderly patients with cancer with onco-geriatric assessment.

This study propose to associate the collection of the results with the Mini-Cog and the CODEX with the passing of the MoCA and the MMS tests, as well as a neuropsychological assessment, in order to determine if the patients have cognitive impairments, to evaluate the sensitivity of these 4 screening tests in elderly patients seeking treatment for their cancer. The results of this study will make it possible, where appropriate, to adapt the practice in the context of oncogeriatric assessment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology

NCT02558907

Geriatrics Cancer

COMPLETED

Cognitive Status Assessment In Elderly Patients With Active Treatment For Haematological Malignancies

NCT04673305

Cognitive Impairment Haematological Malignancy Chemo-brain

UNKNOWN NA

Interest of Two Digital Devices for the Diagnosis of Neurocognitive Disorders in Elderly People With Cognitive Symptoms.

NCT06032611

UNKNOWN NA

Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders

NCT01316562

Alzheimer's Disease Impaired Cognition Memory Disorders

UNKNOWN

Screening of Psycho-cognitive Troubles in Elderly Patients

NCT00831805

Psycho-cognitive Troubles

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Passation of MMS and MoCA tests associated to passation of neuropsychological test

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Passation of neuropsychological test

Passation of MoCA and MMS tests associated with neuropsychological test

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged over 70 years
* Patient with cancer (solid tumor or haemopathy) for whom a first line treatment is envisaged (whatever it is). Surgery and radiotherapy are allowed before entry into the study.
* Patient candidate for oncogeriatric assessment
* Patient agree to participate in the study
* Using the French language

Exclusion Criteria

* Primary central nervous system or cerebral metastasis
* Evolutionary psychiatric pathology known (e.g. schizophrenia)
* Severe Visual and / or Auditory Impairment
* Patients unable to respond to cognitive tests
* Patient (s) deprived of liberty, under guardianship or curatorship
* Refusal of participation

Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No